Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer. - Wikidata - wikimedia - TriplyDB

Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer.

Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer.

http://www.wikidata.org/entity/Q33765404

about

Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.

P2860

Q42708335-703E55D2-F272-4EF1-AA30-F11871EBE934

P2860

Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer.

http://www.wikidata.org/entity/Q33765404

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Adjuvant endocrine therapy alo ...... luminal A type breast cancer.

@ast

Adjuvant endocrine therapy alo ...... luminal A type breast cancer.

@en

type

label

Adjuvant endocrine therapy alo ...... luminal A type breast cancer.

@ast

Adjuvant endocrine therapy alo ...... luminal A type breast cancer.

@en

prefLabel

Adjuvant endocrine therapy alo ...... luminal A type breast cancer.

@ast

Adjuvant endocrine therapy alo ...... luminal A type breast cancer.

@en

P1433

Q33765404-934715DE-88AE-4A1B-88C4-92177A435020

P1476

Q33765404-5E8B6B1A-064F-4F15-B701-56DA6B2CE2CD

P2093

Q33765404-238F393E-6BE6-4FCF-9E82-344305CAA55B

Q33765404-2466EA28-2CDC-4DA0-B773-F96A44F84897

Q33765404-287152C3-9814-4812-87AF-3BAA5778A745

Q33765404-2C290F9F-E0DA-47F2-83CD-D43EACD8F1EA

Q33765404-86E20551-1049-46FE-A3F2-D111EC215BF7

Q33765404-8D29EC3F-93F5-41A8-B13C-80D1F1042369

Q33765404-94A14C79-A872-43B0-9DA6-AEEAE6AA0948

Q33765404-E61F85FC-3E89-4053-A289-738B9BDC4E3A

Q33765404-F55A2E8F-0220-4853-8769-4A71DD6B7029

Q33765404-FBC687B1-71FB-4884-910F-0EB0FE41E65D

P2860

Q33765404-192546C4-562C-417E-A2BC-C9A6759F445D

Q33765404-3098EFB9-405E-4E83-80A7-9917C5ED3D81

Q33765404-31E49548-E327-4553-AEA5-CC94C5AAB737

Q33765404-327C358D-EBE1-4E13-85C5-CA5D57332670

Q33765404-3312E5F8-5DAC-42F7-A28E-475E5B5D4BAB

Q33765404-4F23273F-0E1B-4B2D-B9F2-D7E386C8BCF5

Q33765404-6192E325-2411-4B1A-9844-2C136CFD4C8D

Q33765404-8A604C1B-D059-4A89-95A0-7ECA29B7F1F7

Q33765404-923AC34A-BD6F-46C3-929D-B71AD52C0D41

Q33765404-932E5D0C-0518-4266-B005-8A2692AF0B99

P304

Q33765404-E38B2C22-97E1-44C5-8D33-F902D555364A

P31

Q33765404-2ACC640C-E20E-4447-BF6A-3C2DE9E8318A

P356

Q33765404-3EAE7828-35F5-4D3D-8F1E-0FC390760CF2

P407

Q33765404-E9817542-3272-40D5-802B-C5F31BF6330C

P433

Q33765404-72668125-E9C7-4D90-AFF6-6129C0615E5C

P478

Q33765404-3B37D75F-B594-4086-9843-7C2733A628B9

P577

Q33765404-85A90EF3-5629-4E6E-967C-1AB405BBFCC4

P698

Q33765404-351264D8-2FE8-488E-8AEB-B3F9AAF49D81

P932

Q33765404-904EDFB9-7713-4383-B295-27B92813C42A

P356

MD.0000000000006777

P1433

P1476

Adjuvant endocrine therapy alo ...... luminal A type breast cancer.

@en

P2093

Hyun-June Paik

http://www.w3.org/2001/XMLSchema#string

Isaac Kim

http://www.w3.org/2001/XMLSchema#string

Jai Min Ryu

http://www.w3.org/2001/XMLSchema#string

Jeong Eon Lee

http://www.w3.org/2001/XMLSchema#string

Jonghan Yu

http://www.w3.org/2001/XMLSchema#string

Se Kyung Lee

http://www.w3.org/2001/XMLSchema#string

Seok Jin Nam

http://www.w3.org/2001/XMLSchema#string

Seok Won Kim

http://www.w3.org/2001/XMLSchema#string

Soo Youn Bae

http://www.w3.org/2001/XMLSchema#string

Sungmin Park

http://www.w3.org/2001/XMLSchema#string

P2860

Single agent versus combination chemotherapy for metastatic breast cancer

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.

Gene-expression signatures in breast cancer.

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays.

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.

P304

e6777

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000006777

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28562530

http://www.w3.org/2001/XMLSchema#string

P932

5459695

http://www.w3.org/2001/XMLSchema#string